Jin Yang Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,204	1,780	5,118	753.56	11,720
Short-Term Investments	-	-	2,600	7,890	120
Trading Asset Securities	3,684	233.78	877.27	1,851	3,035
Cash & Short-Term Investments	5,888	2,013	8,595	10,494	14,875
Cash Growth	192.43%	-76.58%	-18.09%	-29.45%	179.33%
Accounts Receivable	23,065	26,098	21,711	19,885	16,670
Other Receivables	80.84	399.99	76.11	63.14	42.37
Receivables	23,445	26,498	21,788	20,248	17,012
Inventory	15,622	14,623	17,353	15,423	9,060
Prepaid Expenses	48.31	57.15	44.01	42.83	35.76
Other Current Assets	1,021	162.97	248.99	120.07	21.97
Total Current Assets	46,024	43,355	48,029	46,329	41,005
Property, Plant & Equipment	47,664	43,494	44,136	43,794	39,363
Long-Term Investments	1,774	1,243	3,087	4,279	4,238
Other Intangible Assets	6,537	5,043	4,886	3,573	1,870
Long-Term Accounts Receivable	-	-	-	0	-0
Long-Term Deferred Charges	848.88	1,188	1,630	1,407	-
Other Long-Term Assets	164,814	132,951	17,838	15,062	12,025
Total Assets	267,809	227,574	119,907	114,444	98,502
Accounts Payable	3,028	4,206	2,444	2,536	265.09
Accrued Expenses	2,571	2,534	2,554	2,245	2,061
Short-Term Debt	1,120	2,781	12,631	19,530	19,822
Current Portion of Long-Term Debt	75,300	1,200	-	-	-
Current Portion of Leases	195.31	221.68	207.76	198.45	113.92
Current Income Taxes Payable	-	998.77	1,374	1,442	678.45
Current Unearned Revenue	79.64	13.96	8.9	11.93	53.21
Other Current Liabilities	5,784	7,838	5,292	4,974	4,149
Total Current Liabilities	88,078	19,794	24,511	30,938	27,143
Long-Term Debt	-	75,300	-	-	-
Long-Term Leases	141.32	179.24	98.45	253.46	76.7
Pension & Post-Retirement Benefits	-	620.19	431.1	302.76	-
Long-Term Deferred Tax Liabilities	17,073	9,707	4,772	4,757	3,688
Other Long-Term Liabilities	2,659	2,096	511.02	618	2,277
Total Liabilities	107,952	107,696	30,323	36,869	33,184
Common Stock	7,067	6,326	6,008	6,000	6,000
Additional Paid-In Capital	23,142	13,366	9,737	9,625	9,625
Retained Earnings	109,566	88,666	62,149	51,884	40,626
Treasury Stock	-	-5,643	-5,643	-5,643	-3,069
Comprehensive Income & Other	20,081	17,164	17,333	15,709	12,136
Shareholders' Equity	159,857	119,878	89,583	77,575	65,318
Total Liabilities & Equity	267,809	227,574	119,907	114,444	98,502
Total Debt	76,757	79,682	12,937	19,982	20,013
Net Cash (Debt)	-70,869	-77,668	-4,341	-9,488	-5,138
Net Cash Per Share	-	-6298.40	-347.94	-705.79	-450.13
Filing Date Shares Outstanding	-	11.43	10.79	10.78	11.18
Total Common Shares Outstanding	-	11.43	10.79	10.78	11.18
Working Capital	-42,054	23,561	23,518	15,391	13,862
Book Value Per Share	-	10490.95	8300.54	7199.14	5843.71
Tangible Book Value	153,320	114,834	84,697	74,002	63,448
Tangible Book Value Per Share	-	10049.58	7847.79	6867.59	5676.41
Land	31,652	27,366	26,901	23,983	19,589
Buildings	18,937	18,906	18,906	18,906	18,906
Machinery	21,025	19,700	19,272	18,782	19,455
Construction In Progress	17.2	86.6	32	1,157	448.88

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.